Corpn. to formulate action plan as Kozhikode joins WHO's age-friendly cities list
Kozhikode Corporation will formulate elaborate plans to coordinate the future activities of Kozhikode, which was recently included in the World Health Organisation's Global Network of Age-Friendly Cities and Communities (GNAFCC).
Mayor Beena Philip told the media here on Monday (May 5) that the Corporation council will discuss and decide what more the city can do to ensure the welfare and happiness of elderly citizens. The council will consider various factors such as societal attitudes towards senior citizens, creating a friendly environment in public spaces, transportation, housing, community support, healthcare services, and communication. Being included in the network will ensure financial support from the World Health Organisation for future activities in this sector.
WHO Focal Point Praveen G. Pai handed over the certificate of inclusion to Mayor Beena Philip at an event held at the Corporation office on Monday. Deputy Mayor C.P. Musafar Ahamed, standing committee chairpersons P. Divakaran and P.C. Rajan, secretary K.U. Bini, health officer T.K. Munavar Rahman, and geriatric psychiatrist Sheeba Nainan from IMHANS were present at the press meet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 hours ago
- Time of India
Fake doctor booked for selling expired drugs from clinic in Kozhikode
T'puram: The drugs control department has initiated legal action against an alleged fake doctor in Kozhikode who provided expired medicines from his clinic. The raid at Marad medical centre, operating under Kozhikode Corporation, was conducted following a complaint from a patient in palliative care. Legal action was taken against the owner of the establishment EK Kannan. Health minister Veena George said that strict action will be taken against those selling expired medicines. "As using expired medicines can lead to serious health issues, consumers should be vigilant. If any pharmacies or clinics are found providing expired medicines, it should be reported to the drugs control department on toll-free number 1800 425 3182. Strict measures will be enforced," the minister said, adding that further inspections will be intensified in the coming days. During the inspection at the Marad clinic, a large quantity of modern medicine was found stored for sale without any documentation. Most of the medicines discovered at the establishment were expired. It was found that Kannan was treating patients with these expired medicines. He did not possess the qualifications as a registered medical practitioner nor the drug licences required for selling these medicines. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is it better to shower in the morning or at night? Here's what a microbiologist says CNA Read More Undo Based on this, the medicines at the establishment were seized. The medicines and documents were presented at the Kozhikode judicial first class magistrate court. Additionally, the police registered a case. Drugs controller K Sujith Kumar has instructed a detailed investigation into how the expired medicines reached the establishment, based on the medicines and documents found. The inspection was conducted under the coordination of Kozhikode assistant drugs controller in charge Sudheesh KV and supervised by Kozhikode drugs inspector Shanthi Krishna, with participation from drugs inspectors Noufal CV and Neethu K. Follow more information on Air India plane crash in Ahmedabad here . Get real-time live updates on rescue operations and check full list of passengers onboard AI 171 .
&w=3840&q=100)
Business Standard
19 hours ago
- Business Standard
Bharat Biotech signs pact with GSK to develop Shigella vaccine candidate
Bharat Biotech on Thursday announced its partnership with UK-based pharma company GSK for the development and potential use of the Shigella vaccine candidate altSonflex1-2-3. As part of the agreement, Bharat Biotech will lead the further development of altSonflex1-2-3, including Phase 3 clinical trials, regulatory advancement and large-scale manufacturing. GSK, on the other hand, will support the programme by assisting with clinical trial design, securing external funding and contributing to the access and delivery plans and commercialisation strategy. The company said that the agreement marks a significant step in advancing the vaccine, which targets shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five years of age in low- and middle-income countries (LMICs). 'The vaccine candidate has already demonstrated a strong safety and immunogenicity profile in both European and African trials, including in the primary target population of nine-month-old infants,' it added. Commenting on the development, Krishna Ella, Executive Chairman at Bharat Biotech, said that with no approved vaccine currently available and antimicrobial resistance on the rise, there is an urgent need for scalable, science-backed solutions focused on LMICs. 'This collaboration combines our strengths in innovation, manufacturing and global health commitment.' According to the World Health Organisation (WHO), Shigella was the second-leading cause of diarrhoeal mortality in 2016 (latest data) among all ages and the leading bacterial cause of diarrhoea, accounting for approximately 212,000 deaths and about 13 per cent of all diarrhoea-associated deaths. The disease is a major contributor to child morbidity and mortality, and the emergence of drug-resistant strains underscores the urgent need for a preventive vaccine. The standard of care for shigellosis primarily involves managing dehydration and using antibiotics. While mild cases often resolve with rest and fluid replacement, more severe cases or those with weakened immune systems may benefit from antibiotics like ciprofloxacin or azithromycin. Thomas Breuer, Chief Global Health Officer at GSK, said that by helping reduce illness and antibiotic use, this vaccine has the potential to play a critical role in combating antimicrobial resistance (AMR). The companies claimed that the vaccine candidate has broad serotype coverage, an innovative Generalised Modules for Membrane Antigens (GMMA)-based platform and robust early clinical results. 'GMMA technology is a platform that uses bacterial outer membranes to deliver the O antigen to the immune system, allowing for high-yield production, which creates affordable vaccines for underserved populations,' they added in a statement.
United News of India
a day ago
- United News of India
India reports 7,151 active Covid-19 cases; six new deaths in last 24 hrs
New Delhi, June 12 (UNI) India's total number of Covid-19 cases has reached 7,151 as of 8 AM on Thursday, according to the Ministry of Health and Family Welfare. In the past 24 hours, 33 new infections have been confirmed, though case data from West Bengal is still awaited. Additionally, six new deaths linked to Covid-19 were reported in the last 24 hours: three from Kerala, two from Karnataka, and one from Maharashtra. These bring the total number of Covid-related deaths in 2025 to 74. On a positive note, more than 8,000 individuals have recovered from the virus so far this year. While several states have reported modest increases in active cases, Kerala remains the worst affected, with 2,223 active infections as of Thursday. Other states with relatively high caseloads include Gujarat, West Bengal, Delhi, and Maharashtra, based on data from the national COVID-19 dashboard. Health authorities attribute the current rise in infections to new Omicron sub-variants including JN.1, NB.1.8.1, LF.7, and XFC. These strains are noted for their high transmissibility but are causing milder illness compared to earlier variants. The World Health Organisation (WHO) has classified them as "Variants Under Monitoring", indicating that while they are not currently a serious threat, their progress should be observed closely. Covid-19, caused by the SARS-CoV-2 virus, has now transitioned into a seasonal pattern similar to the flu. Though no longer considered an emergency, the virus continues to circulate and may pose risks, especially to vulnerable populations. UNI AJ ARN
